HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,100 | +5.9% | 15,500 | 0.0% | 0.54% | +14.5% |
| Q2 2023 | $559,085 | -5.6% | 15,500 | 0.0% | 0.48% | -9.9% |
| Q1 2023 | $591,945 | -16.8% | 15,500 | +24.0% | 0.53% | -19.5% |
| Q4 2022 | $711,250 | +43.9% | 12,500 | 0.0% | 0.66% | +31.5% |
| Q3 2022 | $494,250 | -10.1% | 12,500 | 0.0% | 0.50% | -5.9% |
| Q2 2022 | $550,000 | -22.1% | 12,500 | -29.4% | 0.53% | -9.1% |
| Q1 2022 | $705,876 | +5.8% | 17,700 | +6.6% | 0.58% | +7.6% |
| Q4 2021 | $667,486 | – | 16,600 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |